Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival
出版年份 2014 全文链接
标题
Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival
作者
关键词
Docetaxel, Gemcitabine, Resected Patient, Venous Resection, Borderline Resectable Pancreatic Cancer
出版物
ANNALS OF SURGICAL ONCOLOGY
Volume 21, Issue 5, Pages 1530-1537
出版商
Springer Nature
发表日期
2014-01-29
DOI
10.1245/s10434-014-3486-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
- (2013) Helmut Oettle et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Classic Whipple versus pylorus-preserving pancreaticoduodenectomy in the ACS NSQIP
- (2013) Stefan W. Leichtle et al. JOURNAL OF SURGICAL RESEARCH
- Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens
- (2013) Jean Robert Delpero et al. HPB
- Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer
- (2013) Ching-Wei D. Tzeng et al. HPB
- Pancreatic Ductal Adenocarcinoma
- (2012) Ioannis T. Konstantinidis et al. ANNALS OF SURGERY
- CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
- (2012) Werner Hartwig et al. ANNALS OF SURGICAL ONCOLOGY
- Open-Label, Multicenter, Randomized Phase III Trial of Adjuvant Chemoradiation Plus Interferon Alfa-2b Versus Fluorouracil and Folinic Acid for Patients With Resected Pancreatic Adenocarcinoma
- (2012) Jan Schmidt et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of Morbidity and Mortality Following Hepato-Pancreato-Biliary Surgery
- (2012) Peter J. Kneuertz et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Number of Lymph Nodes Evaluated: Prognostic Value in Pancreatic Adenocarcinoma
- (2012) Marianne Huebner et al. JOURNAL OF GASTROINTESTINAL SURGERY
- N0/N1, PNL, or LNR? The Effect of Lymph Node Number on Accurate Survival Prediction in Pancreatic Ductal Adenocarcinoma
- (2012) Nakul P. Valsangkar et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Pancreatectomy Combined with Superior Mesenteric Vein–Portal Vein Resection for Pancreatic Cancer: A Meta-analysis
- (2012) Yanming Zhou et al. WORLD JOURNAL OF SURGERY
- Pancreatic Cancer Surgery in the New Millennium
- (2011) Werner Hartwig et al. ANNALS OF SURGERY
- Neoadjuvant/Preoperative Gemcitabine for Patients with Localized Pancreatic Cancer: A Meta-analysis of Prospective Studies
- (2011) Angelo Andriulli et al. ANNALS OF SURGICAL ONCOLOGY
- Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent
- (2011) Skye C. Mayo et al. CANCER
- Trends in Hospital Volume and Operative Mortality for High-Risk Surgery
- (2011) Jonathan F. Finks et al. NEW ENGLAND JOURNAL OF MEDICINE
- NeoGemTax: Gemcitabine and Docetaxel as Neoadjuvant Treatment for Locally Advanced Nonmetastasized Pancreatic Cancer
- (2011) Klaus Sahora et al. WORLD JOURNAL OF SURGERY
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
- (2010) John P. Neoptolemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Status of Neoadjuvant Therapy for Resectable Pancreatic Cancer
- (2010) John P. Hoffman Surgical Oncology Clinics of North America
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
- (2010) Sonja Gillen et al. PLOS MEDICINE
- A Systematic Review of Resectability and Survival After Concurrent Chemoradiation in Primarily Unresectable Pancreatic Cancer
- (2009) Alessio G. Morganti et al. ANNALS OF SURGICAL ONCOLOGY
- Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
- (2009) Mark P. Callery et al. ANNALS OF SURGICAL ONCOLOGY
- The “Artery First” Approach for Resection of Pancreatic Head Cancer
- (2009) Jürgen Weitz et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Most Pancreatic Cancer Resections are R1 Resections
- (2008) Irene Esposito et al. ANNALS OF SURGICAL ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma
- (2008) William F. Regine et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Douglas B. Evans et al. JOURNAL OF CLINICAL ONCOLOGY
- Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease
- (2008) Matthew H.G. Katz et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More